Latham & Watkins LLP represented Angion in the offering and private placement.Angion Biomedica Corp. (NASDAQ:ANGN) has announced the pricing of its initial public offering of 5 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
